0001764013-23-000044.txt : 20230414 0001764013-23-000044.hdr.sgml : 20230414 20230414163117 ACCESSION NUMBER: 0001764013-23-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230412 FILED AS OF DATE: 20230414 DATE AS OF CHANGE: 20230414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MIGAUSKY GEORGE V CENTRAL INDEX KEY: 0001134365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38906 FILM NUMBER: 23821611 MAIL ADDRESS: STREET 1: C/O DYAX CORP. STREET 2: 300 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunovant, Inc. CENTRAL INDEX KEY: 0001764013 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832771572 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-580-3099 MAIL ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp DATE OF NAME CHANGE: 20190108 4 1 wf-form4_168150426702734.xml FORM 4 X0407 4 2023-04-12 0 0001764013 Immunovant, Inc. IMVT 0001134365 MIGAUSKY GEORGE V 320 W 37TH STREET, 6TH FLOOR NEW YORK NY 10018 1 0 0 0 0 Common Stock 2023-04-12 4 A 0 12523 0 A 122508 D Stock Option (right to buy) 14.7 2023-04-12 4 A 0 16260 0 A 2033-04-12 Common Stock 16260.0 16260 D Represents the number of shares underlying restricted stock units awards ("RSUs"). The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date. /s/ Eva Renee Barnett, attorney-in-fact for George V. Migausky 2023-04-14